TY - JOUR
T1 - Burden of scabies in a Ghanaian penitentiary
AU - Amoako, Yaw Ampem
AU - Oppong, Michael Ntiamoah
AU - Laryea, Dennis Odai
AU - Kyem, Gloria
AU - Gyabaah, Solomon
AU - Agbanyo, Abigail
AU - Agbavor, Bernadette
AU - Kotey, Nana Konama
AU - Dzathor, Irene
AU - Owusu-Antwi, Felicia
AU - Asiedu, Kingsley
AU - Phillips, Richard Odame
AU - Stienstra, Ymkje
N1 - Publisher Copyright:
© 2024 Amoako et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2024/12/6
Y1 - 2024/12/6
N2 - Background There is a dearth of information concerning the epidemiology of human scabies in prisons. Therefore, we aimed to assess the burden of scabies and ascertain if prevalence was high enough to warrant mass drug administration (MDA) with ivermectin in a medium security prison in central Ghana. Methods We conducted a cross-sectional study in December 2022 and recruited inmates at the Kumasi central prison in Ghana. Medical history and demographic information was collected using a REDCap questionnaire. A standardised skin examination of exposed regions of the body was performed on all participants and scabies was diagnosed based on the criteria of the International Alliance for the Control of Scabies (IACS). Results Of the 559 participants, 19 (3.4%) were female. The median (IQR) age was 36 (33–40) years. There were 368 cases (65.8%) of scabies which was mostly located on the hands, fingers and finger webs. No female inmate had scabies. Scabies severity was predominantly mild (63.3%) or moderate (30.7%). Among males, the median (IQR) number of persons per cell was 115 (56–118) and 7 (7–8) for female prisoners. 79.2% of 96 individuals previously treated in the preceding two months still demonstrated skin manifestations of scabies. Impetigo was found in 12.9% of participants. Seventeen percent of participants with scabies had impetigo compared to 5.8% in individuals without scabies [RR 2.9 (95% CI 1.6–5.5)]. Conclusion A very high proportion of inmates suffered from scabies in the prison. MDA with ivermectin and health education are needed to reduce the burden of scabies in the prison. Its implementation and effectiveness should be studied.
AB - Background There is a dearth of information concerning the epidemiology of human scabies in prisons. Therefore, we aimed to assess the burden of scabies and ascertain if prevalence was high enough to warrant mass drug administration (MDA) with ivermectin in a medium security prison in central Ghana. Methods We conducted a cross-sectional study in December 2022 and recruited inmates at the Kumasi central prison in Ghana. Medical history and demographic information was collected using a REDCap questionnaire. A standardised skin examination of exposed regions of the body was performed on all participants and scabies was diagnosed based on the criteria of the International Alliance for the Control of Scabies (IACS). Results Of the 559 participants, 19 (3.4%) were female. The median (IQR) age was 36 (33–40) years. There were 368 cases (65.8%) of scabies which was mostly located on the hands, fingers and finger webs. No female inmate had scabies. Scabies severity was predominantly mild (63.3%) or moderate (30.7%). Among males, the median (IQR) number of persons per cell was 115 (56–118) and 7 (7–8) for female prisoners. 79.2% of 96 individuals previously treated in the preceding two months still demonstrated skin manifestations of scabies. Impetigo was found in 12.9% of participants. Seventeen percent of participants with scabies had impetigo compared to 5.8% in individuals without scabies [RR 2.9 (95% CI 1.6–5.5)]. Conclusion A very high proportion of inmates suffered from scabies in the prison. MDA with ivermectin and health education are needed to reduce the burden of scabies in the prison. Its implementation and effectiveness should be studied.
UR - http://www.scopus.com/inward/record.url?scp=85211700246&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0312108
DO - 10.1371/journal.pone.0312108
M3 - Article
C2 - 39642185
AN - SCOPUS:85211700246
SN - 1932-6203
VL - 19
JO - PLoS ONE
JF - PLoS ONE
IS - 12
M1 - e0312108
ER -